| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | CEO And President | See Remarks
1 company
Kumar Neil is a Chief Executive Officer at BridgeBio Pharma, Inc.. Recent SEC Form 4 filings include 0 buys and 24 sells.
Estimated insider holdings value: $39.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2025 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 80,000 | $42.63 | $3,410,450.42 | -0.5% | +21.3% | - | |
| May 20, 2025 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sale+OE | 101,156 | $33.38 | $3,376,741.11 | -1.9% | +45.4% | - | |
| Apr 22, 2025 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 75,000 | $34.11 | $2,558,025.00 | -1.5% | +34.3% | - | |
| Mar 25, 2025 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 75,000 | $36.87 | $2,764,942.50 | -1.5% | +14.8% | +94.9% | |
| Feb 25, 2025 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 75,000 | $33.57 | $2,517,971.14 | -0.7% | -3.6% | +94.0% | |
| Feb 19, 2025 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sale+OE | 31,543 | $36.14 | $1,140,024.26 | -6.9% | -7.1% | +94.9% | |
| Jan 29, 2025 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 600,000 | $36.31 | $21,788,650.42 | -3.7% | -0.1% | +117.0% | |
| Nov 19, 2024 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sell | 27,389 | $22.41 | $613,825.89 | -0.3% | +57.5% | +190.8% | |
| Aug 19, 2024 | BBIO Bridgebio Pharma, Inc. | Chief Executive Officer | Sale+OE | 27,389 | $24.69 | $676,256.05 | -0.3% | -11.2% | +94.3% | |
| Nov 17, 2023 | BBIO Bridgebio Pharma, Inc. | CEO And President | Sale+OE | 51,552 | $29.10 | $1,500,037.52 | -0.5% | +34.1% | -18.9% |